Drug Enforcement Administration October 2017 – Federal Register Recent Federal Regulation Documents

Bulk Manufacturer of Controlled Substances Application: Euticals Inc.
Document Number: 2017-23556
Type: Notice
Date: 2017-10-30
Agency: Drug Enforcement Administration, Department of Justice
Lon F. Alexander, M.D.; Decision and Order
Document Number: 2017-23339
Type: Notice
Date: 2017-10-26
Agency: Drug Enforcement Administration, Department of Justice
Harinder Takyar, M.D.; Decision and Order
Document Number: 2017-23338
Type: Notice
Date: 2017-10-26
Agency: Drug Enforcement Administration, Department of Justice
Yoon H. Choi, M.D.; Decision and Order
Document Number: 2017-23329
Type: Notice
Date: 2017-10-26
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Galephar Pharmaceutical Research, Inc.
Document Number: 2017-23328
Type: Notice
Date: 2017-10-26
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl Into Schedule I
Document Number: 2017-23206
Type: Rule
Date: 2017-10-26
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioids, N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (ortho-fluorofentanyl or 2-fluorofentanyl), N-(1-phenethylpiperidin-4- yl)-N-phenyltetrahydrofuran-2-carboxamide (tetrahydrofuranyl fentanyl), and 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (methoxyacetyl fentanyl), into Schedule I. This action is based on a finding by the Administrator that the placement of ortho- fluorofentanyl, tetrahydrofuranyl fentanyl, and methoxyacetyl fentanyl into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, ortho- fluorofentanyl, tetrahydrofuranyl fentanyl, and methoxyacetyl fentanyl.
Schedules of Controlled Substances: Placement of AB-CHMINACA, AB-PINACA and THJ-2201 Into Schedule I
Document Number: 2017-22325
Type: Rule
Date: 2017-10-16
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Drug Enforcement Administration places N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), N-(1-amino- 3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB- PINACA), and [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1- yl)methanone (THJ-2201), including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into schedule I of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This rule continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle AB-CHMINACA, AB- PINACA and THJ-2201.
Warren B. Dailey, M.D.; Decision and Order
Document Number: 2017-21382
Type: Notice
Date: 2017-10-05
Agency: Drug Enforcement Administration, Department of Justice
William J. O'Brien, III, D.O.; Decision and Order
Document Number: 2017-21380
Type: Notice
Date: 2017-10-05
Agency: Drug Enforcement Administration, Department of Justice